How to Take Laxogenin: Dosage, Timing and Duration

Laxogenin is marketed in the UK and elsewhere as a "natural anabolic" derived from plants, often with bold promises of muscle gain without hormonal side effects. Before thinking about how much to take and when, it is worth knowing how little is actually known about it in humans. Our editorial team has looked at what the labels say, what the science says, and where the genuine risks lie.

What laxogenin is and where it comes from

Laxogenin is a spirostane-type steroidal sapogenin, a plant compound structurally related to brassinosteroids, the growth-regulating hormones of plants. It is typically described on labels as extracted from the rhizome of Smilax sieboldii, although in practice much of what is sold is produced by semi-synthesis from diosgenin, a sapogenin obtained from wild yam or fenugreek.

A closely related compound, 5α-hydroxy-laxogenin, is the version most commonly listed on sports supplements. Manufacturers often present the two interchangeably, which already tells you something about the precision of the market. The chemical difference matters for regulators and testing laboratories, even if it rarely features in marketing copy.

The appeal of laxogenin rests largely on animal and cell research with brassinosteroids. In one frequently quoted rat study, the brassinosteroid homobrassinolide increased lean mass and grip strength and appeared to act through the Akt signalling pathway rather than the androgen receptor. Marketers have extrapolated this to laxogenin, despite the fact that the two compounds are not the same molecule.

To date, our editorial team is not aware of any published, peer-reviewed randomised controlled trial testing laxogenin or 5α-hydroxy-laxogenin for muscle growth, strength or body composition in people. Every statement about its effects in humans is, at best, an extrapolation and, at worst, advertising.

What doses appear on labels

Because there are no human dose-finding studies, there is no evidence-based dose for laxogenin. What exists are manufacturers' recommendations, which vary considerably. Most products sold to UK consumers state between 25 mg and 100 mg per serving, with some "high-strength" versions going beyond that. These figures are commercial choices, not clinically validated amounts.

The table below summarises the typical patterns seen on product labels. It is descriptive only: it shows what the market does, not what is proven to be effective or safe.

Independent analyses of products labelled as laxogenin have repeatedly raised concerns about what is actually inside the capsule. Some products contain far less than declared, while others have been found to include undeclared substances, including compounds that behave like anabolic steroids. For a consumer, the number printed on the tub therefore says relatively little about the true dose.

For these reasons, the editorial team does not recommend any particular laxogenin dose. If someone chooses to use a product anyway, the most defensible position is not to exceed the manufacturer's stated serving, not to combine several laxogenin-containing products, and to stop immediately at the first sign of adverse effects.

Timing: with food or without

Steroidal sapogenins are fat-soluble and poorly soluble in water. On general pharmacological principles, compounds of this type tend to be absorbed better alongside a meal containing some fat. That is why many labels advise taking laxogenin with breakfast and, where two servings are suggested, with another main meal.

Some marketing material advises taking laxogenin before training "to maximise the anabolic window". There is no pharmacokinetic data in humans to support any specific timing relative to exercise. The concept of a narrow anabolic window has also been softened considerably by research on protein timing, which shows that total daily intake matters more than precise scheduling.

Splitting a daily amount into two servings is a common label instruction. It may reduce mild stomach upset, which is sometimes reported with saponin-rich plant products, but it should not be presented as a way of enhancing effects that have not been demonstrated in the first place.

What clearly does influence results is everything around the supplement: adequate total protein (roughly 1.6 g per kilogram of body weight per day in most resistance-training research), sufficient energy intake, progressive training and sleep. Without these, no capsule will produce visible changes.

Duration of use and so-called cycles

Laxogenin is often sold with instructions to use it in "cycles" of around eight weeks followed by a break of similar length. This language is borrowed from anabolic steroid culture and is not based on any measured effect of laxogenin, such as receptor down-regulation or tolerance, in humans.

Because laxogenin is promoted as non-hormonal, manufacturers usually state that it requires no post-cycle therapy. If a product is genuinely pure laxogenin, that is plausible. The problem is that adulterated products may contain hormonally active compounds, in which case hormonal suppression could occur without the user being aware of it.

From a practical point of view, the editorial team suggests that anyone trying laxogenin should treat any use as a short, time-limited experiment with a clear end date rather than an indefinite habit. Keeping a simple log of weight, training performance and how you feel helps distinguish a real change from expectation and normal training progress.

If you notice changes such as reduced libido, testicular discomfort, acne, mood swings or unusual fatigue, these are not "normal" effects of a plant extract. They warrant stopping the product and speaking to a GP, who may consider blood tests including liver function and hormone levels.

Safety, legal status and anti-doping

In the UK, laxogenin is sold as a food supplement and is not a licensed medicine. Food supplements are not assessed by the MHRA for efficacy before sale, and the Food Standards Agency and local trading standards rely on manufacturers to ensure their products are safe. This framework offers far less assurance than medicines regulation.

Laxogenin itself is not named on the World Anti-Doping Agency's Prohibited List. However, the list includes a catch-all clause for "other anabolic agents" and substances with similar chemical structure or biological effects. For athletes tested by UK Anti-Doping, the main risk is contamination: a positive test caused by an adulterated product is still treated under strict liability.

• Contamination: laxogenin products have been flagged for undeclared anabolic substances.
• Quality: actual content can differ substantially from the label.
• Unknown long-term effects: no human safety data exist for regular use.
• Vulnerable groups: pregnant or breastfeeding women, under-18s and people with liver disease should avoid it.

Athletes who are subject to testing should only use supplements that have been batch-tested under a recognised third-party programme, and even then such certification reduces rather than eliminates risk. Many sports nutritionists simply advise tested athletes to avoid laxogenin altogether.

Conclusions of the editorial team

Laxogenin is a plant-derived steroidal sapogenin promoted as a natural muscle builder, but its reputation rests on research with different compounds in animals and cells, not on human trials.

There is no evidence-based dose, timing or duration. Label doses of 25–100 mg per day reflect marketing decisions, and the true content of products has been shown to vary, sometimes with undeclared anabolic substances.

For most people, money spent on laxogenin is better directed towards sufficient protein, well-planned training and adequate sleep, all of which have robust evidence behind them. Tested athletes should be particularly cautious because of strict liability rules.

If you are interested in this area, the editorial team also recommends our articles on ecdysterone and its anti-doping status, on how to read supplement labels critically, and on evidence-based protein intake for muscle gain.

References

1. Esposito D, Komarnytsky S, Shapses S, Raskin I. Anabolic effect of plant brassinosteroid. FASEB J. 2011;25(10):3708–3719.
2. Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med. 2018;52(7):439–455.
3. Geyer H, Parr MK, Koehler K, et al. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008;43(7):892–902.
4. Cohen PA, Wen A, Gerona R. Prohibited stimulants in dietary supplements after enforcement action by the US Food and Drug Administration. JAMA Intern Med. 2018;178(12):1721–1723.
5. Jäger R, Kerksick CM, Campbell BI, et al. International Society of Sports Nutrition position stand: protein and exercise. J Int Soc Sports Nutr. 2017;14:20.
6. World Anti-Doping Agency. The World Anti-Doping Code International Standard: Prohibited List. Montreal: WADA; updated annually.